BRIEF: MicroPort ‘s revenue soars in first half of 2025
Medical robotics company Shanghai MicroPort MedBot (Group) Co. Ltd. (2252.HK) said on Thursday that its revenue surged 70% to 80% in the first half of this year from 99.24 million yuan ($14 million) in the same period of 2024.
The sharp uptick stemmed chiefly from strong growth for its core Toumai endoscopic surgical robots, which secured 18 new orders in the six-month period. The company’s SkyWalker orthopedic surgical robots also saw steady sales growth. Following regulatory approval and its market launch, demand for the company’s R-ONE vascular interventional robot grew as well.
As its revenue grew rapidly and the company attained more cost reductions and better efficiency, its adjusted net loss for the period narrowed 40% year-on-year to 125 million yuan.
Shares of MicroPort opened up 1.3% at HK$18.60 on Friday. The stock is up 62% since the start of the year.
By Lau Chi Hang
To subscribe to Bamboo Works weekly free newsletter, clickhere
Related Articles
RELATED ARTICLES
-
Hong Kong Robotics’ stock soars on robotics pivot, but does it have legs?
0370.HK -
Shoucheng sheds ‘old economy’ label with robotic pivot
0697.HK
- Yunji rides robotics wave to Hong Kong IPO with A-list of backers
- Switchbot taps market frenzy for robotic stocks
- Why can’t humanoid robots bear the weight of intelligence?
-
Investors are tapped for more cash as iMotion’s ambitions take flight
1274.HK
-
RoboSense steers towards profits as LiDAR gains traction
2498.HK
